Cargill invests $15 million in new bioindustrial plant in India
06 August 2020, New Delhi – Cargill has opened a high-pressure hydrogenation plant in Kurkumbh, Maharashtra, India to manufacture superior bypass fat, a health and nutrition supplement for dairy cattle. It will be launched and marketed under the global brand Carfe, which is technologically advanced, providing better digestion and more energy to the cattle.
Read: Bayer completes the sale of its Animal Health business unit to Elanco
India has been the largest milk producer in the world for over two decades. However, milk productivity per animal is still low in comparison to the world average. Enhancing milk production has been a priority to grow farm income and global competitiveness of the Indian dairy sector. To address this need,
Built with an investment of US$ 15 million, the plant has an annual capacity of 35000 tons, making it one of the largest facilities to manufacture bypass fats and specialty waxes in the country. This investment leverages Cargill’s global presence in agriculture supply chain, expertise in bioindustrial manufacturing technology and reach and market coverage in dairy nutrition in India, to bring a best in class solution for dairy farmers in India.
Read: Global food prices rise in July: FAO
This plant will also manufacture specialty vegetable oil based waxes for industrial application, marketed under the brand name Agri-Pure™, which has application in tyre, plastic and candle industry.
Quality Nutrition for Dairy Cattle
Carfe has proven to substantially improve the quality of nutrition for dairy cattle, resulting in better reproductive health and milk production, translating to improved earnings for farmers. This product is already available in developed dairy cattle markets worldwide and will now be locally manufactured at Cargill’s new bioindustrial plant in Kurkumbh and made available to dairy farmers and feed manufacturers in India.
Read: China reports Fall Armyworm in corn growing areas
“This launch is in line with our ambitions of continuing to remain the leading supplier and trusted partners for feed millers and farmers in the country. Our long-term experience in bypass fats and specialty waxes, combined with our local insights and this investment will go a long way in demonstrating our commitment to the country, in keeping with our organizational goal of nourishing the world. It also demonstrates our commitment to supporting the local economy with the addition of 50 new manufacturing jobs,” said Keerthy Pethaiyan, regional director, Cargill Bioindustrial, India.
Cargill’s bioindustrial business has a leading presence in sustainable bio-based products including Distilled Fatty Acids used by the paints, inks and coatings industry in India. In 2016, Cargill set up a plant in Maharashtra at the same location to manufacture FR3® (natural ester dielectric fluid) which is used in transformers.
Read: Safeguarding Australia from seedy biosecurity risks
Today it has a strong position in the natural ester-based dielectric fluid market – with FR3 having strong brand equity. With this investment, Cargill is further expanding its presence in the bioindustrial sector locally to fuel growth ambitions in the country, while supporting growth opportunities globally.
“India is a key growth market for Cargill and line with our commitment to the country, this marks a continuation of our investment in India. By building upon our operations at this facility, we will increase our regional footprint and enhance our local capabilities to better support the needs of our local customers as well as multi-national customers across the globe,” said Kurtis Miller, global managing director, Industrial Segment, Cargill Bioindustrial.
Photo credit: IBM Research on Visualhunt.com / CC BY-ND